Distinguished in Age-Related Macular Degeneration (ARMD)

Gerald M. Liew

Sydney, NSW, AU 
Distinguished in Age-Related Macular Degeneration (ARMD)
Sydney, NSW, AU 
OverviewLocationsClinical Research

Overview

Gerald Liew practices in Sydney, Australia. Mr. Liew is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Vitrectomy.

His clinical research consists of co-authoring 157 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 61 articles and participated in 1 clinical trial in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Sydney, NSW, Australia
Other Locations
Westmead, NSW, Australia
Camperdown, NSW, Australia
Camperdown, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 09, 2025
Intervention Type: Drug
Study Drug: EXN407
Study Phase: Phase 1/Phase 2

157 Total Publications

Development and Validation of a Deep Learning System for the Provision of a District-Wide Diabetes Retinal Screening Service.
Development and Validation of a Deep Learning System for the Provision of a District-Wide Diabetes Retinal Screening Service.
Journal: Clinical & experimental ophthalmology
Published: February 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Liew's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile